Oppenheimer & Co. Inc. Acquires 830 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Oppenheimer & Co. Inc. raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 59,320 shares of the healthcare conglomerate’s stock after acquiring an additional 830 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in UnitedHealth Group were worth $30,008,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently bought and sold shares of the business. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth $30,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the third quarter valued at about $37,000. Highline Wealth Partners LLC bought a new stake in UnitedHealth Group during the third quarter valued at about $55,000. Legacy Investment Solutions LLC bought a new stake in UnitedHealth Group during the third quarter valued at about $57,000. Finally, DecisionPoint Financial LLC boosted its position in UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

UNH has been the subject of several recent analyst reports. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. Truist Financial lowered their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Wells Fargo & Company decreased their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, Piper Sandler decreased their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Price Performance

UNH opened at $463.69 on Thursday. The stock’s 50-day moving average price is $517.50 and its 200 day moving average price is $558.41. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $426.73 billion, a price-to-earnings ratio of 29.92, a PEG ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 EPS. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.81%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.